TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tianda Pharmaceuticals Ltd. ( (HK:0455) ) has provided an announcement.
Tianda Pharmaceuticals Limited announced changes in its board composition effective June 27, 2025, in response to amendments in the Listing Rules and Corporate Governance Code. Mr. CHIU Sung Hong has stepped down from the Nomination Committee, while Dr. XIAN Yanfang has been appointed as a member. Additionally, Mr. LAM Yat Fai is now the lead independent non-executive director. These changes aim to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance practices.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the development, manufacturing, and marketing of pharmaceutical products, with a significant presence in the Hong Kong market.
Average Trading Volume: 83,657
Technical Sentiment Signal: Sell
Current Market Cap: HK$292.4M
Find detailed analytics on 0455 stock on TipRanks’ Stock Analysis page.